{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T19:21:19Z","timestamp":1790536879785,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"13","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["106-3114-Y404-002"],"award-info":[{"award-number":["106-3114-Y404-002"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.vaccine.2018.09.034","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T10:10:23Z","timestamp":1552039823000},"page":"1897-1903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development"],"prefix":"10.1016","volume":"37","author":[{"family":"Ting-Hui-Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Yuan","family":"Chia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Qi","family":"Yeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U-Ser","family":"Jeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Guey","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Shi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.09.034_b0005","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.tim.2014.08.008","article-title":"Pandemic potential of avian influenza A (H7N9) viruses","volume":"22","author":"Watanabe","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.vaccine.2018.09.034_b0010","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJMoa1304459","article-title":"Human infection with a novel avian-origin influenza A (H7N9) virus","volume":"368","author":"Gao","year":"2013","journal-title":"New England J Med"},{"key":"10.1016\/j.vaccine.2018.09.034_b0015","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0042-6822(89)90153-0","article-title":"Evolution of the hemagglutinin of equine H3 influenza viruses","volume":"169","author":"Kawaoka","year":"1989","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.09.034_b0020","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1073\/pnas.96.4.1651","article-title":"Origin and evolution of the 1918 \u201cSpanish\u201d influenza virus hemagglutinin gene","volume":"96","author":"Reid","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2018.09.034_b0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0042-6822(78)90153-8","article-title":"On the origin of the human influenza virus subtypes H2N2 and H3N2","volume":"87","author":"Scholtissek","year":"1978","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.09.034_b0030","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/nature08182","article-title":"Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic","volume":"459","author":"Smith","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2018.09.034_b0035","doi-asserted-by":"crossref","first-page":"e0119792","DOI":"10.1371\/journal.pone.0119792","article-title":"Characterization of influenza A (H7N9) viruses isolated from human cases imported into Taiwan","volume":"10","author":"Yang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.09.034_b0040","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(13)60943-5","article-title":"The first case of H7N9 influenza in Taiwan","volume":"381","author":"Chang","year":"2013","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.vaccine.2018.09.034_b0045","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.1093373","article-title":"Structure of the uncleaved human H1 hemagglutinin from the extinct 1918 influenza virus","volume":"303","author":"Stevens","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.09.034_b0050","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.virusres.2016.09.014","article-title":"Structural and functional specificity of Influenza virus haemagglutinin and paramyxovirus fusion protein anchoring peptides","volume":"227","author":"Kordyukova","year":"2017","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2018.09.034_b0055","doi-asserted-by":"crossref","first-page":"14610","DOI":"10.1073\/pnas.2235620100","article-title":"Influenza virus hemagglutinin concentrates in lipid raft microdomains for efficient viral fusion","volume":"100","author":"Takeda","year":"2003","journal-title":"PNAS"},{"key":"10.1016\/j.vaccine.2018.09.034_b0060","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.virol.2010.12.003","article-title":"Influenza virus assembly and budding","volume":"411","author":"Rossman","year":"2011","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2018.09.034_b0065","doi-asserted-by":"crossref","first-page":"13673","DOI":"10.1128\/JVI.79.21.13673-13684.2005","article-title":"Influenza virus hemagglutinin (H3 subtype) requires palmitoylation of its cytoplasmic tail for assembly: M1 proteins of two subtypes differ in their ability to support assembly","volume":"79","author":"Chen","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.09.034_b0070","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1128\/JVI.74.10.4634-4644.2000","article-title":"Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins","volume":"74","author":"Zhang","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.09.034_b0075","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1046\/j.1398-9219.2003.0138.x","article-title":"Features of influenza HA required for apical sorting differ from those required for association with DRMs or MAL","volume":"4","author":"Tall","year":"2003","journal-title":"Traffic (Copenhagen, Denmark)"},{"key":"10.1016\/j.vaccine.2018.09.034_b0080","doi-asserted-by":"crossref","first-page":"8645","DOI":"10.1128\/JVI.00281-12","article-title":"Structure and receptor complexes of the hemagglutinin from a highly pathogenic H7N7 influenza virus","volume":"86","author":"Yang","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.09.034_b0085","doi-asserted-by":"crossref","first-page":"e20052","DOI":"10.1371\/journal.pone.0020052","article-title":"Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines","volume":"6","author":"Lin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.09.034_b0090","unstructured":"Wood JMaW, M.S. History of inactivated influenza vaccines; 1998."},{"key":"10.1016\/j.vaccine.2018.09.034_b0095","doi-asserted-by":"crossref","first-page":"4709","DOI":"10.1016\/j.vaccine.2010.04.083","article-title":"Global production of seasonal and pandemic (H1N1) influenza vaccines in 2009\u20132010 and comparison with previous estimates and global action plan targets","volume":"28","author":"Partridge","year":"2010","journal-title":"Vaccine"},{"issue":"Suppl 5","key":"10.1016\/j.vaccine.2018.09.034_b0100","doi-asserted-by":"crossref","first-page":"B40","DOI":"10.1016\/S0264-410X(02)00509-1","article-title":"Selection of influenza vaccine strains and developing pandemic vaccines","volume":"20","author":"Wood","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.034_b0105","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.biologicals.2009.02.014","article-title":"FluBlok, a next generation influenza vaccine manufactured in insect cells","volume":"37","author":"Cox","year":"2009","journal-title":"Biol: J Int Assoc Biol Stand"},{"key":"10.1016\/j.vaccine.2018.09.034_b0110","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1093\/infdis\/173.6.1467","article-title":"Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults","volume":"173","author":"Treanor","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.09.034_b0115","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1016\/j.vaccine.2015.03.009","article-title":"Recombinant virus-like particles elicit protective immunity against avian influenza A(H7N9) virus infection in ferrets","volume":"33","author":"Liu","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.034_b0120","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1016\/j.vaccine.2015.10.097","article-title":"Randomized comparison of the safety of Flublok\u00ae versus licensed inactivated influenza vaccine in healthy, medically stable adults \u226550 years of age","volume":"33","author":"Izikson","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.034_b0125","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1177\/2051013615595595","article-title":"Safety, efficacy, and immunogenicity of Flublok in the prevention of seasonal influenza in adults","volume":"3","author":"Cox","year":"2015","journal-title":"Therap Adv Vacc"},{"key":"10.1016\/j.vaccine.2018.09.034_b0130","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/irv.12285","article-title":"Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins","volume":"8","author":"Blanchfield","year":"2014","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2018.09.034_b0135","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01202-17","article-title":"Inactivated H7 Influenza virus vaccines protect mice despite inducing only low levels of neutralizing antibodies","volume":"91","author":"Kamal","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.09.034_b0140","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.vaccine.2013.11.036","article-title":"One-shot vaccination with an insect cell-derived low-dose influenza A H7 virus-like particle preparation protects mice against H7N9 challenge","volume":"32","author":"Klausberger","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.034_b0145","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/infdis\/jiu528","article-title":"A single immunization with modified vaccinia virus ankara\u2013based influenza virus H7 vaccine affords protection in the Influenza A(H7N9) pneumonia ferret model","volume":"211","author":"Kreijtz","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.09.034_b0150","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1006\/jmbi.2001.4644","article-title":"Stabilization of short collagen-like triple helices by protein engineering","volume":"308","author":"Frank","year":"2001","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2018.09.034_b0155","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/j.vaccine.2005.11.005","article-title":"Expression and purification of an influenza hemagglutinin\u2013one step closer to a recombinant protein-based influenza vaccine","volume":"24","author":"Wang","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.034_b0160","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1107\/S1399004714016617","article-title":"Protein\u2013ligand interactions investigated by thermal shift assays (TSA) and dual polarization interferometry (DPI)","volume":"71","author":"Gr\u00f8ftehauge","year":"2015","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"10.1016\/j.vaccine.2018.09.034_b0165","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1128\/JVI.02278-13","article-title":"Structural stability of influenza A(H1N1)pdm09 virus hemagglutinins","volume":"88","author":"Yang","year":"2014","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.09.034_b0170","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1107\/S0909049510034308","article-title":"Design and construction of a compact end-station at NSRRC for circular-dichroism spectra in the vacuum-ultraviolet region","volume":"17","author":"Liu","year":"2010","journal-title":"J Synchrotron Radiat"},{"key":"10.1016\/j.vaccine.2018.09.034_b0175","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1107\/S0021889809043271","article-title":"A small\/wide-angle X-ray scattering instrument for structural characterization of air-liquid interfaces, thin films and bulk specimens","volume":"43","author":"Jeng","year":"2010","journal-title":"J Appl Crystallogr"},{"key":"10.1016\/j.vaccine.2018.09.034_b0180","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1021\/acs.jpclett.6b02722","article-title":"Probing the acid-induced packing structure changes of the molten globule domains of a protein near equilibrium unfolding","volume":"8","author":"Yeh","year":"2017","journal-title":"J Phys Chem Lett"},{"key":"10.1016\/j.vaccine.2018.09.034_b0185","doi-asserted-by":"crossref","first-page":"7947","DOI":"10.1039\/C6CP08820A","article-title":"Oligomerization process of Bcl-2 associated X protein revealed from intermediate structures in solution","volume":"19","author":"Shih","year":"2017","journal-title":"Phys Chem Chem Phys"},{"key":"10.1016\/j.vaccine.2018.09.034_b0190","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1107\/S0021889812007662","article-title":"New developments in the ATSAS program package for small-angle scattering data analysis","volume":"45","author":"Petoukhov","year":"2012","journal-title":"J Appl Crystallogr"},{"key":"10.1016\/j.vaccine.2018.09.034_b0195","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1529\/biophysj.105.064154","article-title":"Global rigid body modeling of macromolecular complexes against small-angle scattering data","volume":"89","author":"Petoukhov","year":"2005","journal-title":"Biophys J"},{"key":"10.1016\/j.vaccine.2018.09.034_b0200","doi-asserted-by":"crossref","first-page":"12433","DOI":"10.1128\/JVI.01854-13","article-title":"Structural analysis of the hemagglutinin from the recent 2013 H7N9 influenza virus","volume":"87","author":"Yang","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.09.034_b0205","unstructured":"WHO. World Health Organization. WHO manual on animal influenza diagnosis and surveillance Geneva: WHO; 2002. July 12."},{"key":"10.1016\/j.vaccine.2018.09.034_b0210","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.1124513","article-title":"Structure and receptor specificity of the hemagglutinin from an H5N1 influenza virus","volume":"312","author":"Stevens","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.09.034_b0215","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-5793(99)01475-1","article-title":"Structure of influenza haemagglutinin at neutral and at fusogenic pH by electron cryo-microscopy","volume":"463","author":"Bottcher","year":"1999","journal-title":"FEBS Lett"},{"key":"10.1016\/j.vaccine.2018.09.034_b0220","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1002\/j.1460-2075.1986.tb04367.x","article-title":"Expression of the influenza virus haemagglutinin in insect cells by a baculovirus vector","volume":"5","author":"Kuroda","year":"1986","journal-title":"EMBO J"},{"key":"10.1016\/j.vaccine.2018.09.034_b0225","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/S0264-410X(98)00494-0","article-title":"Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes","volume":"17","author":"Crawford","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.034_b0230","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1099\/vir.0.067108-0","article-title":"Thirty years of baculovirus-insect cell protein expression: from dark horse to mainstream technology","volume":"96","author":"van Oers","year":"2015","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2018.09.034_b0235","doi-asserted-by":"crossref","first-page":"6200","DOI":"10.1128\/JVI.00187-08","article-title":"Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virus","volume":"82","author":"Wei","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.09.034_b0240","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1016\/j.vaccine.2014.07.074","article-title":"Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process","volume":"32","author":"Buckland","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.09.034_b0245","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1472-6750-12-77","article-title":"Pandemic influenza vaccine: characterization of A\/California\/07\/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability","volume":"12","author":"Feshchenko","year":"2012","journal-title":"BMC Biotech"},{"key":"10.1016\/j.vaccine.2018.09.034_b0250","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02104-16","article-title":"Lateral organization of influenza virus proteins in the budozone region of the plasma membrane","volume":"91","author":"Leser","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2018.09.034_b0255","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12896-014-0111-y","article-title":"Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss","volume":"14","author":"Holtz","year":"2014","journal-title":"BMC Biotech"},{"key":"10.1016\/j.vaccine.2018.09.034_b0260","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1016\/j.vaccine.2013.07.043","article-title":"Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A\/Anhui\/1\/2013 (H7N9) protection and heterologous A\/chicken\/Jalisco\/CPA1\/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus","volume":"31","author":"Smith","year":"2013","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18312945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:31:02Z","timestamp":1759401062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18312945"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":52,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0264410X18312945"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.034","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving immunogenicity of influenza virus H7N9 recombinant hemagglutinin for vaccine development","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}